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Abstract
In women, excess production of the male hormone, testosterone (T), is accompanied by insulin resistance. However,
hyperandrogenemia is also associated with b-cell dysfunction and type 2 diabetes raising the possibility that androgen
receptor (AR) activation predisposes to b-cell failure. Here, we tested the hypothesis that excess AR activation produces
systemic oxidative stress thereby contributing to b-cell failure. We used normal female mice (CF) and mice with androgen
resistance by testicular feminization (Tfm). These mice were exposed to androgen excess and a b-cell stress induced by
streptozotocin (STZ). We find that following exposure to T, or the selective AR-agonist dehydrotestosterone (DHT), CF mice
challenged with STZ, which are normally protected, are prone to b-cell failure and insulin-deficient diabetes. Conversely, T-
induced predisposition to b-cell failure is abolished in Tfm mice. We do not observe any proapoptotic effect of DHT alone or
in the presence of H2O2 in cultured mouse and human islets. However, we observe that exposure of CF mice to T or DHT
provokes systemic oxidative stress, which is eliminated in Tfm mice. This work has significance for hyperandrogenic women;
excess activation of AR by testosterone may provoke systemic oxidative stress. In the presence of a prior b-cell stress, this
may predispose to b-cell failure.
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Introduction
The association between hyperandrogenicity and diabetes in
women has been known for almost a century [1,2]. Indeed,
women with polycystic ovarian syndrome (PCOS) develop insulin
resistance independently of obesity [3]. Furthermore, testosterone
(T) infusion in healthy women decreases insulin-stimulated whole
body glucose uptake [4]. The role of excess T in promoting skeletal
muscle insulin resistance is also well established from studies in
female rodents [5,6]. Women with hyperandrogenemia, however,
show various degrees of pancreatic b-cell dysfunction [7,8,9,10].
In some studies of women with PCOS, b-cell dysfunction was
closely associated to the degree of androgenicity, independently of
insulin resistance, raising the possibility that excess T may
predispose to secondary b-cell failure [9,10]. Consistent with this
hypothesis, in mice, T accelerates the hyperglycemic decompen-
sation in experimental models of insulin-dependent diabetes in
which b-cell destruction is induced by oxidative stress or
inflammation [11,12,13,14]. Thus, excess T in women may
exacerbate the deleterious effect of oxidative stress. Indeed, T
provokes oxidative stress in cultured prostate cancer cells [15] and
conversely, the AR antagonist flutamide protects against liver
injury following trauma-hemorrhage in male by reducing
oxidative stress [16]. In addition, T overload in rats increases
reactive oxygen species-induced oxidative damage and lipid
peroxidation in muscle [17]. Finally, hyperandrogenemia in
women with PCOS is accompanied with systemic oxidative stress
[18]. Thus, T may provoke systemic oxidative stress which may
act as a second hit to provoke b-cell failure in predisposed
individuals. T exerts its actions via a ligand activated transcription
factor, namely, the androgen receptor (AR). The extent to which
the AR plays a role in systemic oxidative stress and b-cell failure in
female rodents with hyperandrogenemia is unknown.
Here, we studied the role of androgen and the AR on b-cell
survival and systemic oxidative stress in littermate control females
(CF) and androgen receptor deficient mice with testicular
feminization (Tfm). These mice were exposed to excess T with
or without oxidative stress induced by streptozotocin (STZ).
Results
AR activation predisposes to STZ-induced diabetes in
female mice
To produce a b-cell stress in vivo, we used a single high-dose
injection of STZ (150 mg/kg). Females are partially protected from
STZ induced- stress and b-cell failure because of estradiol
protection [19,20]. In order to address the effects of AR activation
in b-cell death, we compared littermate normal control and AR-
deficient mice with the testicular feminizing (Tfm) mutation. The
Tfm mouse is a well-established mouse model of total androgen
resistance with a mutant and inactive AR [21,22,23]. Because AR
gene is on the X chromosome, females are heterozygous carrier and
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We treated the mice with vehicle (V), T, or the non-aromatizable
and pure AR agonist, dihydrotestosterone (DHT). Following STZ
challenge, control female (CF) mice exposed to V were protected by
endogenous estradiol and showed minimal predisposition from
STZ-induced insulin-deficient diabetes (Fig. 1 A–C). Conversely,
CF mice exposed to T (Fig. 1A–C) or DHT (Fig. 1D–F,) became
vulnerable to STZ and showed a severe predisposition to insulin-
deficient diabetes. We observed that, both in normal condition and
following T exposure, Tfm mice were protected against STZ-
induced insulin deficient diabetes (Fig. 1A–C). Consistent with the
results shown previously, CF mice exposed to STZ only exhibited
minimal decrease in b-cell number and pancreas insulin concen-
trations when exposed to T (Fig. 2A, B). Conversely, CF mice
exposed to T or DHT exhibited a dramatic loss of b-cell number
and pancreasinsulin concentration(Fig. 2A–D). We found that Tfm
mice were protected from the deleterious effect of T on b-cell
destruction; they retained a normal b-cell number and pancreas
insulin concentration following exposure to STZ (Fig. 2 A, B).
AR activation does not provoke inflammation or
apoptosis in female islets
Pro-inflammatory cytokines (PIC), and in particular IL-1b, are
thought to be important pathogenic effectors responsible for the
Figure 1. Excess AR activation exacerbates STZ-induced diabetes in mice. (A) Cumulative incidence of diabetes (random-fed blood glucose
.250 mg/dl) in CF and Tfm treated with V or T (n=10215) after STZ challenges (150 mg/kg). (B) Random-fed blood glucose in V or T treated mice
was measured after STZ injection (day 8). (C) The ratio of random-fed insulin (pg/ml)/glucose (mg/dl) in vehicle or T treated mice at day 8 was used as
an index of insulin deficiency. (D) Cumulative incidence of diabetes in CF and CF treated with DHT mice (n=10215) after STZ challenges (150 mg/
kg). (E) Random-fed blood glucose was measured after STZ injection (day 8) in V- or DHT-treated mice. (F) The ratio of random-fed insulin (pg/ml)/
glucose (mg/dl) at day 8 in V- or DHT-treated mice. Values represent the mean 6 SE.
* P,0.05. V=vehicle.
doi:10.1371/journal.pone.0011302.g001
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type 2 diabetes [24]. Massive induction of apoptosis in b-cells can
be elicited in vitro by a combination of IL-1b plus IFNc and/or
TNFa [24,25]. Because AR is a ligand-activated transcription
factor expressed in islets (Fig. 3A), we looked at the possibility that
T increases PIC gene expression from islets. However, we
observed no effect of T on PIC gene expression in islets from
wild type (WT) mice treated by T (Fig. 3B), eliminating the
existence of a local T-induced inflammation leading to b-cell
destruction. Since T does not provoke inflammation in the islet in
vivo, we tested the possibility that direct islet exposure to excess
androgen provokes apoptosis. The pro-apoptotic effect of DHT
was thus investigated in cultured female mouse and human islets
using a luminescent assay for activated caspase-3, the ‘‘execution-
er’’ of apoptosis. In a dose-response experiment, we did not
observe that DHT, even used at pharmacological concentrations,
increased caspase 3 activity, eliminating a direct pro-apoptotic
effect of DHT alone on b-cell survival in vitro (Fig. 3C and E).
Finally, we looked at the possibility that, as observed in vivo
following STZ challenge, DHT exacerbates the pro-apoptotic
effect of oxidative stress induced by H2O2.H 2O2 provoked a
significant increase in caspase 3 activity in mouse and human
islets, and interestingly this was prevented by DHT at low
physiological concentration (10
212M) (Fig. 3D and F). Conversely,
the pro-apoptotic effect of H2O2 was not increased by DHT at
concentrations ranging from physiological to pharmacological
(Fig. 3D and F). Thus, excess AR activation in cultured islets does
not increase the susceptibility to H2O2-induced apoptosis.
AR activation provokes systemic oxidative stress in
female mice
Since T exacerbates STZ-induced islet destruction but does not
provoke b-cell apoptosis by itself, we reasoned that T may increase
systemic oxidative stress. Indeed, women with hyperandrogenism
show systemic oxidative stress [18]. Thus, we looked at the effect of
AR activation on systemic markers of oxidative stress in CF and
Figure 2. Excess AR activation exacerbated STZ-induced b-cell loss in mice. (A) b-cell number per section from CF and Tfm treated with V or
T. (B) Pancreatic insulin concentration in mice from (A). (C) b-cell number in CF treated with V or DHT-treated mice. (D) Pancreas insulin content in
mice from (C). Values represent the mean 6 SE.
* P,0.05, #P=0.08. V=vehicle.
doi:10.1371/journal.pone.0011302.g002
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of all major biomolecules, such as DNA, proteins, and lipids. To
measure oxidative stress, we quantified lipid peroxidation in serum
using the classical thiobarbituric acid reactive substances (TBARS)
method [26]. In basal conditions, we observed a minor decrease in
serum TBARS concentrations in Tfm compared to CF mice, T
and DHT exposure produced an increased in serum TBARS
concentrations in CF mice (Fig. 4A and B), but this effect was not
observed in Tfm mice (Fig. 4A). Systemic oxidative stress may
originate from the NADPH oxidase (NOX) complex from
accumulated fat [27]. NOX is a major source of reactive oxygen
species (ROS) in various cells. We quantified the expression of
gp91
phox and Nox4, a homolog of gp91
phox, which is specific to
white adipose tissue (WAT) [28] and is not expressed in
macrophages [29]. None of these genes were elevated (Fig. 5)
ruling out the possibility that oxidative stress comes from fat.
Discussion
We show that excess T provokes systemic oxidative stress and,
in synergism with a concomitant b-cell injury, predisposes to b-cell
failure in female mice via AR-dependent mechanisms.
Paradoxically, in the non-obese diabetic (NOD) type 1 diabetic
model, the female predisposition to diabetes is prevented by
androgens [30]. The NOD mouse, however, is the only model of
b-cell failure that does not exhibit the classical male predominance
that characterizes rodents and humans [31]. The gender
dimorphism in NOD mice is related to an enhanced target
organ-specific estrogen and androgen sensitivity of lymphocyte in
[32,33] and a specific gene that segregate with diabetes and
modulates a target organ-specific androgen sensitivity [34].
Therefore, the NOD model, although excellent for studying
autoimmune b-cell death is not appropriate for studying the role of
sex hormones in islet biology and diabetes.
To determine whether excess AR activation exacerbates the
susceptibility to a b-cell stress in vivo, we used the STZ mouse
model. STZ does not provoke b-cell dysfunction as encountered in
women with PCOS. However, STZ provokes an increase in islet
ROS leading to cellular damage and apoptosis and is a useful
pharmacological tool to mimic an in vivo islet stress induced by
hyperglycemia or cytokines in diabetes [35,36]. We have
successfully used the STZ model of gender dimorphism to show
that estrogen favor islet survival through at least three estrogen
receptors [19,20]. T overload increases oxidative stress, ROS-
induced oxidative damage, and lipid peroxidation in vitro and in
vivo [15,16,17]. In addition, women with hyperandrogenism have
systemic oxidative stress [18] and b-cell dysfunction [7,8,9,10].
Here, we show for the first time that T and DHT produce systemic
oxidative stress in mice through an AR-dependent mechanism.
This is associated to an increased severity of b-cell destruction in
female mouse islets challenged with STZ. Since STZ produces an
islet stress, AR-induced systemic oxidative stress may synergize
with STZ to act as a second hit, aggravating b-cell injury.
However, excess AR activation without prior b-cell injury is not
sufficient since T infusion in healthy women does not produce b-
cell dysfunction [4] .Thus, in women with a prior b-cell defect,
excess T may predispose to b-cell failure through the cumulative
action of various b-cell stresses including insulin resistance and
circulating oxidative stress.
The question that remains unanswered is whether direct AR
activation in b-cells alters survival and function in vivo.I n
Figure 4. Excess AR activation provokes systemic oxidative
stress. (A) Plasma TBARS concentrations were measured in CF and Tfm
mice treated with V or T. (B) TBARS level in CF treated with V or DHT
mice. Values represent the mean 6 SE.
* P,0.05.
doi:10.1371/journal.pone.0011302.g004
Figure 5. Testosterone does not affect the expression of NOX
subunits in WAT. Gene expression of gp91
phox and NOX4 in
perigonadal fat pads from CF treated with V or T. Values represent
the mean 6 SE.
* P,0.05.
doi:10.1371/journal.pone.0011302.g005
Figure 3. Excess AR activation in islets does not provoke inflammation or apoptosis. (A) AR expression in pancreatic islets was measured
by western blotting. (B) Relative gene expression of proinflammatory cytokines (PIC) in the islets. (C) Caspase 3/7 activity was measured in female
mouse islets by luminescence following DHT dose-response treatment at the indicated concentrations. (D) Caspase 3/7 activity was measured in
female mouse islets by luminescence following exposure to H2O2 (100 mM) and DHT dose-response treatment at the indicated concentrations. (E)
Caspase 3/7 activity was measured in human islets as indicated in (C). (F) Caspase 3/7 activity was measured in human islets as indicated in (D). Values
represent the mean 6SE.
* P,0.05, **P,0.01, ***P,0.001 each condition vs. vehicle only treatment.
doi:10.1371/journal.pone.0011302.g003
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apoptosis. T induction of the AR in endothelial cells increases in
NF-kB nuclear translocation and pro-inflammatory gene expres-
sion [38] and T enhances apoptotic damage in human endothelial
cells cultured in stress conditions [39]. In mice, however, T excess
does not increase islet pro-inflammatory cytokines production
ruling out an effect of AR in producing local islet inflammation. In
addition, in cultured mouse and human islets, DHT does not show
a significant pro-apoptotic effect and does not exacerbate the
susceptibility to another b-cell stressor like oxidative stress, event at
pharmacological concentrations. This suggests that if excess AR
action in b-cells impairs survival in vivo, AR must also be activated
in non-islets tissues to promote b-cell stress via a circulating factor
or neuronal input on islets. Studies are ongoing to determine the
role of AR in the predisposition to b-cell failure in females in vivo.
What is the origin of systemic oxidative stress in hyperandro-
genic mice? Systemic oxidative stress may originate from
accumulated fat [27], or androgen-stimulated circulating mono-
nuclear cells (MNC). Against the involvement of WAT, is the
observation that WAT mass and the expression of molecular
markers of NOX, a major source of ROS in various cells, are not
increased in our hyperandrogenic mice. With regard to the second
possibility, ROS generation from MNCs is increased in PCOS
women independent of obesity and correlated to testosterone levels
[18]. Thus, excess androgen in females may provoke systemic
oxidative stress via AR action on MNC. Further studies are
needed to determine the role of AR in b-cells and MNCs in the
predisposition to b-cell failure in female mice.
Materials and Methods
Animals
Mice carrying the Tfm mutation on a C57BL/6 background
and C57BL/6 mice were purchased from Jackson Laboratory.
Testicular feminization (AR
Tfm) is a dominant spontaneous
mutation on the X chromosome. Females carry the tabby
mutation (Ta) on the other X chromosome (Tfm/Ta). Since the
tabby gene is closely linked to the Tfm mutation, mating between
Ta/Tfm females and Ta/Y males were used to generate carrier
female (Tfm/Ta), affected male (Tfm/Y), and normal male and
female (Ta/Y and Ta/Ta) offspring. All protocols for animal use
and euthanasia were approved by the Animal Care Use
Committee of Northwestern University, in accordance with NIH
guidelines.
Androgen infusion and induction of experimental
diabetes
T, DHT and vehicle (cholesterol) were administered by
subcutaneous 21-day release pellets (5 mg/pellet, Innovative
research of America). One week after pellet insertion, a group of
8-week-old mice were exposed to a single intraperitoneal (IP)
injection of 150 mg/kg of STZ to induce diabetes as described
[19]. Blood glucose was measured every 48 h following STZ
injection. At day 8 following STZ injection, serum was collected
for measurement of insulin concentrations, mice were sacrificed,
and pancreases were processed for measurement of pancreas
insulin concentration.
Pancreas insulin concentration
Whole pancreas was weighed and homogenized in acid/
ethanol. Pancreas homogenates were centrifuged and their
supernatant was used to measure pancreas insulin concentration
as previously described [19].
Islet isolation
Female mouse islets were isolated by collagenase digestion as
described [19]. Briefly, the pancreas was injected through the
pancreatic duct with 2 ml of 2 mg/ml collagenase (Sigma) in
Hanks’ buffered saline solution (HBSS), dissected out, incubated
at 37uC for 15 min, and passed through a 400-mm wire mesh.
The digested pancreas was rinsed with HBSS, and islets were
separated by density gradient in Histopaque (Sigma). After
several washes with HBSS and PBS, islets were then either
cultured in phenol-red free RPMI medium containing 11 mM
glucose, 10% charcoal stripped FBS, 1 mM glutamine, penicillin
(100 U/ml), streptomycin (100 mg/ml) for DHT treatment study
or frozen in liquid nitrogen and then stored at 280uC for RNA
extraction.
DHT stimulation and caspase 3/7 activity assay
Islets were cultured in phenol-red free RPMI medium
containing 11 mM glucose, 10% charcoal stripped FBS. Islets








26M for 48 h in the
presence or absence of H2O2 (100 mM) for 5 hours. Ethanol was
used as the vehicle. Medium was changed daily and DHT was
added daily. Following 48 h DHT treatment, Caspase activity was
measured using Caspase-Glo 3/7 assay kit (Promega) as described
[19,20]. Briefly, islets were collected and centrifuged for 5 min at
1200 rpm, washed with PBS and transferred to a 96-well plate in a
100 ml volume. Islets were then lysed with 100 ml Caspase-Glo 3/7
reagent and incubated at room temperature for 60 min. Luciferase
activity was measured using a Synergy
TM 2 Multi-Mode Microplate
Reader (BioTek). Values are reported as relative luciferase units
corrected for total protein concentration.
Real time RT-PCR
Total RNA was prepared from islets Trizol (Invitrolgen)
following the manufacturer’s instructions. 1((g of total RNA was
reverse transcripted to 20((l cDNA using iScript cDNA Synthesis
Kit (BIO-RAD. Real time PCR was performed using iQTM-
SYBRHGreen Supermix (BIO-RAD). The mRNA expression was
studied by using specific oligonucleotides primers. The threshold
cycle values (CT) were determined as a measure of the cycle
number at which a statistically significant increase in fluorescence
intensity is first detected. Beta actin was used as an endogenous
control to account for possible variations due to differences in
initial RNA quality and the efficiency of the cDNA synthesis
reaction. The abundance of the amplified DNA was then
determined from the CT values and was normalized to the value
for the control gene beta actin to yield the relative abundance.
When comparing samples from two or more experimental groups,
the relative abundance values were normalized to the average
relative abundance for the control female group and the resulting
ratios were presented in figures. The oligonucleotide primers used
were as follows: IL-1b (forward): 59-AGCTCTCCACCTCAATG-
GACAGAA-39, (Reverse) -59 ATTGCTTGGGATCCACAC-
TCTCCA-39; TNF-a (forward): 59-GTC CCC AAA GGG
ATG AGA AGT-39, (reverse) 59-TGA GAT AGC AAA TCG
GCT GAC-39; IFN-c: (forward) 59-ACT GGC AAA AGG ATG
GTG AC-39, (reverse) 59-TGA GCT CAT TGA ATG CTT GG-
39; IL-6: (forward) 59-ACAACCACGGCCTTCCCTACTT-39,
(reverse) 59-CACGATTTCCCAGAGAACATGTG-39; gp91
phox
(forward): 59-TTGGGTCAGCACTGGCTCTG-39, (reverse) 59-
TGGCGGTGTGCAGTGCTATC-39; NOX4: (forward) 59-
TGTTGGGCCTAGGATTGTGTT-39, (reverse) 59- AAAAG-
GATGAGGCTGCAGTTG-39.
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Systemic oxidative stress was assessed by measuring the
concentration of thiobarbituric acid reactive substances (TBARS)
in plasma [26] according to the manufacturer’s instructions
(Zeptometrix).
Statistical analysis
Results are presented as mean 6 SE as specified in figures. All
statistical analyses were performed using the unpaired Student’s
t test. Cumulative incidence of diabetes was determined by
Kaplan-Meier estimates and statistical analysis of differences was
determined by log-rank test. A value of p,0.05 was considered
significant.
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